SUPN Other Disclosure
Gemayel Georges · SEC Form 4 · Filed Nov 4, 2026
Other
Calculated transaction value
$0
Gemayel Georges Director
SUPN
Supernus
SUPN
Transaction date
Nov 2, 2026
Public filing date
Nov 4, 2026
Filing lag
Filed 2 days later
SUPN daily price context
Close on/before transaction
--
Nov 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Director Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 8,613 shares @ $0
- SEC ownership
- Direct
- Transaction code
- J
- Form
- 4
- Filing identifier
- 0001256088-26-000008
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN Current | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |
| Supernus Pharmaceuticals, Inc. SUPN | Other | Nov 2, 2026 | $0 |